Study Evaluating Single Ascending Doses of AAB-001 Vaccine SAD Japanese Patients With Alzheimers Disease

NCT00397891 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

80

Enrollment

INDUSTRY

Sponsor class

Conditions

Alzheimer Disease

Interventions

DRUG: bapineuzumab
DRUG: bapineuzumab
DRUG: bapineuzumab

Sponsor

Wyeth is now a wholly owned subsidiary of Pfizer